Skip to main content
. 2021 Oct 30;49(3):453–462. doi: 10.1007/s10488-021-01175-x

Table 3.

Level and trend changes across TMH-transition by sub-clinic

Outcome Adult Pediatric Substance use
B Lower limit 95% CI Upper limit 95% CI p value B Lower limit 95% CI Upper limit 95% CI p value B Lower limit 95% CI Upper limit 95% CI p-value
% Cancelled visits
 Baseline trend − 0.04 − 0.44 0.37 0.850 − 0.28 − 0.66 0.11 0.153 0.09 − 0.71 0.89 0.822
 Level change − 12.87 − 16.99 − 8.74  < 0.001 − 11.96 − 16.16 − 7.76  < 0.001 − 6.46 − 13.51 0.59 0.070
 Trend change 0.61 0.11 1.11 0.020 0.68 0.12 1.25 0.020 0.33 − 0.95 1.61 0.598
% No shows
 Baseline trend 0.12 0.03 0.22 0.015 0.05 − 0.08 0.18 0.423 0.14 − 0.26 0.55 0.471
 Level change 1.18 − 0.01 2.38 0.052 1.69 − 0.14 3.52 0.069 1.41 − 3.32 6.13 0.542
 Trend change − 0.73 − 0.93 − 0.52  < 0.001 − 0.54 − 0.79 − 0.30  < 0.001 0.02 − 0.57 0.60 0.951

Calculated with Newey-West standard errors